Research Conducted at Bayer CropScience Has Provided New Information about Hormones (Identification of selected in vitro generated phase-I metabolites of the steroidal selective androgen receptor modulator MK-0773 for doping control purposes)
By a News Reporter-Staff News Editor at Biotech Week -- Investigators publish new report on Drugs and Therapies. According to news reporting from Monheim, Germany, by NewsRx journalists, research stated, "Research into developing anabolic agents for various therapeutic purposes has been pursued for decades. As the clinical utility of anabolic-androgenic steroids has been found to be limited because of their lack of tissue selectivity and associated off-target effects, alternative drug entities have been designed and are commonly referred to as selective androgen receptor modulators (SARMs)."
The news correspondents obtained a quote from the research from Bayer CropScience, "While most of these SARMs are of nonsteroidal structure, the drug candidate MK-0773 comprises a 4-aza-steroidal nucleus. Besides the intended therapeutic use, SARMs have been found to be illicitly distributed and misused as doping agents in sport, necessitating frequently updated doping control analytical assays. As steroidal compounds reportedly undergo considerable metabolic transformations, the phase-I metabolism of MK-0773 was simulated using human liver microsomal (HLM) preparations and electrochemical conversion. Subsequently, major metabolic products were identified and characterized employing liquid chromatography-high-resolution/high-accuracy tandem mass spectrometry with electrospray (ESI) and atmospheric pressure chemical ionization (APCI) as well as nuclear magnetic resonance (NMR) spectroscopy. MK-0773 produced numerous phase-I metabolites under the chosen in vitro incubation reactions, mostly resulting from mono-and bisoxygenation of the steroid. HLM yielded at least 10 monooxygenated species, while electrochemistry-based experiments resulted predominantly in three monohydroxylated metabolites. Elemental composition data and product ion mass spectra were generated for these analytes, ESI/APCI measurements corroborated the formation of at least two N-oxygenated metabolites, and NMR data obtained from electrochemistry-derived products supported structures suggested for three monohydroxylated compounds. Hereby, the hydroxylation of the A-ring located N-bound methyl group was found to be of particular intensity."
According to the news reporters, the research concluded: "In the absence of controlled elimination studies, the produced information enables the implementation of new target analytes into routine doping controls and expands the focus of anti-doping efforts concerning this new anabolic agent."
For more information on this research see: Identification of selected in vitro generated phase-I metabolites of the steroidal selective androgen receptor modulator MK-0773 for doping control purposes. European Journal of Mass Spectrometry, 2016;22(2):49-59 (see also Drugs and Therapies).
Our news journalists report that additional information may be obtained by contacting A. Lagojda, Bayer CropScience AG, Alfred-Nobel-Str 50, 40789 Monheim, Germany. Additional authors for this research include D. Kuehne, O. Krug, A. Thomas, T. Wigger, U. Karst, W. Schanzer and M. Thevis.
Keywords for this news article include: Europe, Monheim, Germany, Hormones, Chemicals, Electrochemistry, Drugs and Therapies, Androgens and Anabolic Steroids.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2016, NewsRx LLC